We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Tuberculosis and Polio Vaccines Being Tested for Limited Protection Against Coronavirus

By HospiMedica International staff writers
Posted on 15 Jun 2020
As the COVID-19 pandemic continues to spread globally, scientists are now conducting tests to see if vaccines meant for tuberculosis (TB) and polio can provide protection from the deadly coronavirus.

According to a report by The Washington Post, tests are currently underway to determine if the TB vaccine called bacillus Calmette-Guerin, or BCG, can slow the novel coronavirus. More...
The BCG vaccine has already received approval from the Food and Drug Administration (FDA) and has a long history of safe usage. A team of researchers led by Dr Jeffrey D Cirillo, a professor of microbial pathogenesis and immunology at Texas A&M Health Science Center, is now testing the TB vaccine to see if it can reduce the severity of coronavirus.

“This vaccine has a very broad ability to strengthen your immune response. We call it ‘trained immunity. This could make a huge difference in the next two to three years while the development of a specific vaccine is developed for COVID-19,” said Cirillo in a statement from Texas A&M Health Science Center newsletter.

Azra Raza, a professor of medicine at Columbia University Medical Center, told The Washington Post that BCG could improve people's ability to fight pathogens, even in patients who are given the vaccine for another approved use that is bladder cancer. “Researchers have looked at developing countries where mortality rates are lower, in these countries BCG vaccine is widely used. It’s not like they’re not getting the infection. The rate (of positive infections) is high. But they’re just not dying. It is raging through, but they’re not dying of it,” stated Raza in the report by The Washington Post.

According to The Washington Post report, a group of scientists is also testing the polio vaccine oral OPV and its effect on slowing COVID-19. “Vaccines developed against TB and polio have already been used in millions of people and could offer a low-risk way to rev up the body’s first line of defense, the innate immune system, against a broad array of pathogens, including the coronavirus,” the group said.

Robert Gallo, a world-renowned researcher who co-discovered that HIV is the cause of AIDS, said that OPV had a strong safety record. “This is not complicated, the science is there to support the idea, and we need to act fast,” said Gallo in a statement by the University of Maryland.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.